Helping you stay current in drug monitoring

Categories

Archives

 
 

AMA urges states to act to maintain access to care for patients with pain or OUD

The American Medical Association is urging governors and state legislatures to take action to ensure that patients being treated with opioids, whether for chronic pain or as medication-assisted treatment for substance use disorder, maintain access to their therapies during the coronavirus pandemic. Among their recommendations, they urge officials to:

  1. Adopt Drug Enforcement Administration guidance that allows telemedicine evaluation of new patients for buprenorphine treatment.
  2. Designate medications to treat addiction and overdose as “essential services,” to reduce barriers to access.
  3. Waive limits and restrictions on dose and/or quantity as well as refills for prescriptions for controlled substances.
  4. Encourage telemedicine to replace in-person evaluations and enhance options for home delivery of medications.

The full set of recommendations is available HERE.

American Medical Association. COVID-19 policy recommendations for OUD, pain, harm reduction. July 20, 2020. Accessed July 27, 2020. https://www.ama-assn.org/delivering-care/public-health/covid-19-policy-recommendations-oud-pain-harm-reduction